Saturday, July 31, 2010

Weekend Op-Ed Piece

Have you ever wondered what would would happen to healthcare and our industry if patients (TSB likes that word better than the MBA invented word "consumer"), decided that its time to cut back on medical care and services because they would be responsible for a higher deductible when it comes to their personal healthcare and maintenance? Considering that every CEO whose company's spine revenue is flat, or moving along at a snails pace is crying "market pricing dynamics (another term for we can't gouge the system anymore because we are euthanizing ourselves with commodities)," could we be seeing the initial stages of underutilizing medical care in this country? So why are patient visits and surgical procedures, down from a year ago?

Besides the economy, maybe the reason is that patients are beginning to realize that they do not have to run to the doctor's office every time they feel an ache and pain? A depressed economy, the real definition of a double dip recession, will affect the way medical care is delivered in this country. I know that there are many readers that believe that the state of our economy and healthcare is attributed to the POTUS, but can we talk? The fact is that TSB's diagnosis sees a societal malignancy that is attributed to other political surgeons like Reagan, Bush, Clinton, Bush II and now BO. The current state of affairs did not occur within the last year and a half. Like any disease, this disease has been festering for a long time and now that it is cascading and exacerbated by an out of control society, we have no one else to blame but ourselves. Not only have Americans done a poor job of taking care of themselves, but they have done a poor job of taking care of their country. The same way that TSB makes fun of people like Fender, Will, Shappley, and Bennett, you know the usual suspects that people continue to hire within our industry, we the people continue to re-elect the Ben Nelson's (Insurance Background), Chris Dodd's (Banking), Charlie Rangell's, Nancy Pelosi's, Mitch McConnell's and Harry Reids. Vote these people out. These are people whose time has come and gone, and quite frankly could not give a rat's derriere about anyone else except themselves. Not only should there be term limits, there should be age limits in order to serve the people. But getting back to the gist of this post, maybe patient's are becoming prudent, and through education and the internet they are learning how to take better care of themselves?

Let's face facts, we are a medically addicted society! Just look at all the ridiculous advertisements on TV. My head hurts, take this pill. I have high blood pressure, take that pill. I have a heart condition, this pill will suffice. Need a new knee, try this one. Need a new hip, this is the one for you. I can't get laid, take this pill. Screw the sunset, how about just getting out of seperate bath tubs, it works for me. You get my point. Oh, and by the way, these are the side effects and in case these symptoms arise, call your doctor immediately! How insane are we? By taking care of ourselves, maybe, we will affect the cost of insurance premiums and the spiraling cost of healthcare by driving down the cost of delivery. It's simple economics. So many people are currently unemployed and unaccounted for, that anyone in their right mind would not incur additional expenditures. As more Americans are forced to buy into higher deductible plans by their employers (we have to take care of the shareholders first), many are re-thinking whether or not they need surgery or the need to run to the doctor when they sprain their ankle. Nature has a way of telling you whether you need care of not.

As the unemployment rate increases for the rank and file (remember those that fall through the cracks), everyone loses, meaning, less business across the board for everyone, including spine. How does anyone afford COBRA when the average cost for a single person is $5,5o0 and a family of four would have to pay $14,500 per year? Even if the government (the root of all evil, OOOOOH), subsidizes 65% of the premium, COBRA is prohibitively expensive, and besides the coverage only lasts 15 months, and people who lost their jobs since May do not qualify for the government subsidy.

Recently, some insurance companies reported their quarterly earnings and predicted that this under utilization will be a short-term situation. Maybe those people are just playing the old game of wishful thinking that they teach you when you go to a Deepak Chopra or Tony Roberts meeting. The fact is, that this environment is not going to change for a long time, and it will not be two years. So what is happening? The insurance companies are raising premium even as there is a decline in utilization of healthcare, their justification is the out-of-control cost of delivering healthcare. The mathematics is quite simple, higher insurance premiums and deductibles mean less doctor visits, less doctor visits mean less surgery, which in turn means less money for the doctor, the surgery center and the hospital, less testing means less money for the labs and MRI facilities, a decline in procedures will mean we need less help, which in turn means that there will be less money for all of us.

If greed is not the demise of capitalism, maybe our national stupidity will bring us down. We don't respect one another's differences, we don't want to pay taxes, we pander to illegal aliens (yes business owners you are part of the problem), Spanish is becoming the language of choice (just dial 411 on your cell phone), we spend money without thinking about the potential long-term ramifications of becoming a banana republic, we export jobs and manufacturing to third world countries, we bail out the banks (socialism at its best), and all for the love of profits. In closing, take this time to smell the roses. I know, most of you will say that you have to generate 30% growth for your company, or you will lose your job. My answer to this is, you cannot squeeze blood out of a stone in the current economic climate. Executive management teams must stop living in the past, either they will change, or, the change will change them.


Thursday, July 29, 2010

Synthes Continues to Grow, but, Spine is Sucking Wind!!!!

The Arbeitsgemeinschaft Fur Osteosynthesfragen (whenever TSB says that, I feel like I'm back in the old country yodeling off Jakob Mountain), reported its second quarter 2010 earnings today, and, like many of their counterparts, it seems the spine division offset a strong performance by Synthes Trauma and Cranio-Maxillo Facial. Of course Michael Orsinger in his infinite wisdom told the Street that this performance was offset by pricing pressures in the spine marketplace. TSB believes this has become the "jump on the bandwagon" excuse within the industry for those legacy companies that are "sucking wind." So, why are so many companies choking on the gas pipe? Could it be that there is nothing new in their portfolios? Could it be that many of these companies have kicked the tires on potential acquisitions and realized that there is nothing new?The former investors and management team at N-Spine and Spinal Solutions must be laughing all the way to the bank. Suckerrrrrrrrrrr!

The Big O (If only he had moves like Oscar Robertson) went on to commend the job that Synthes Trauma and CMF did. When the bastard step-child of the company (CMF) outperforms spine, you know there's trouble in paradise. Synthes is evolving into the second coming of Medtronic. Too big to move fast. In addition, how lame is the excuse that challenging economic and industry conditions continue to impact growth. Yes fellow bloggers, Synthes just like every other slim bucket organization is moving manufacturing over to China to minimize manufacturing cost. But wait until they find out that the Chinese are adept at copying implants and selling knock-offs in the Asian Markets. Surprise! Suprise! Surprise!

Wednesday, July 28, 2010

Once again, XLIFTS NuVasive!

NuVasive announced QII 2010 revenue of $119.6 million which was an astounding 35% increase over the $88.5 million for QII in 2009, and a 9.6% increase in revenue over QI of 2010 which was $109.1 million. With two quarters under their belt Lukianov has upped his prediction estimating $485 to $500 million by year end. Given that most of NuVa's products are "me too," it seems that XLIF and Osteocel have grown some big shoulders this year carrying the weight of the Big Bear's predications.

Considering that the guidance for this industry has been downgraded by every analyst under the hot summer sun, and the industry has been slow and flat (TSB is starting to sound like Tom Freidman), kudos must go out to the NuVasive Regional Managers and sales people that continue to accept the Czar's challenge. Talk about putting a bit of pressure on the troops, wait until winter comes. This may be NuVasive's greatest challenge since Adolf Hitler declared his intent to hit the USSR on August 11, 1939. If they continue their campaign to move up the ladder, the Czar must reward his troops with jeweled Faberge eggs and bottles of Chateau 1982 Pauillac. If Lukianov truly believes in patronage, you know what they say, "to the victor belongs the spoils." Besides a nice relaxing dinner at Dolce Pane E Vino would be worth it.


Tuesday, July 27, 2010

FDA Approves Amplify in 6 to 5 Vote

On Tuesday July 27th, 2010 a panel of FDA advisors voted 6 to 5, with 3 abstentions, that the benefits of MSD's experimental spinal fusion device (it's a device?), outweighs the risk. In a close vote, consenting panel advisors believed that the rhBMP-2 worked well enough to overcome major concerns that the studies may indicate a cancer risk for those receiving this material.

Considering that the Evil Empire's sales have been suffering, some analysts believe that this will be a shot in the arm for the company's revenue. The spine division had 3% growth last year, could this be mana from heaven? In addition, could this be the death knell for some of the early stage synthetic bone graft companies, if surgeons decide to jump on the Amplify love train?

The success rate for Amplify was 61% as compared to 56% for those receiving autograft. Results after five years found successful operations for 44% of Amplify patients versus 35% for standard care. I guess it goes to prove TSB's observation, if you have enough of capital and lobbying power anything is possible.

Monday, July 26, 2010

Will the FDA Execute or Issue a Stay?

On Tuesday, July 27th, the FDA will convene an Advisory Panel meeting that will evaluate and question the clinical efficacy of Medtronic's Amplify rhBMP-2 Matrix. The FDA has some major concerns regarding the high number of cancer related incidents in patients that have been treated with the Amplify rhBMP-2 as compared to patients treated without it. For those of you that read our blog, many of you are aware of the cynical comments that have already been posted regarding the name Amplify. For those of you not familiar with our lexicon, the word Amplify means to make larger, greater, or stronger, to enlarge, to extend. And that my fellow readers is what the FDA is concerned with.

The FDA's concerns center on the IDE (Investigational Device Exemption) along with Medtronic's, Wyeth's and Medicare's data. In all likelihood the significance of this data and the reviewers evaluation will determine whether additional evaluations and analyses will be needed. The panel will have to take a position on whether they believe that there is a statistical significant rate of incidence of overall cancer and pancreatic events in patients treated with Amplify (the test group) as compared to the control group.

In addition, the panel is being asked to consider the difference between Medtronic's and Wyeth's clinical studies, the methodology, the location or placement of Amplify in the body, when the patient was treated, the dosing and concentration, length of follow-up and potential patient co-morbidity. What it comes down to fellow bloggers is that the Federalis are concerned about the number of reported pancreatic cancer events in patients treated with the magic dust. An interpretation of this data will focus on patient demographics, limitations, follow-up and validation of the study.

At this juncture we know that any rhBMP-2 is not recommended for use in women of child-bearing age, yet, the panel will also review secondary procedures due to failure where rhBMP-2 had been used. It will be interesting to see who steps up to the plate on behalf of the evil empire. Will it be the usual suspects? The panel members for the FDA will include three cancer experts and an expert in reproductive biology. Hopefully, the FDA will perform a much better and more thorough proctological examination on Amplify and for that matter Medtronic than they did on Infuse. TSB would like to think that surgeons would take pancreatic cancer a little more seriously, than they did having boney ingrowth into the spinal canal, but what do I know, considering that TSB has no financial interest in these products. TSB wants to know what our readers think?


Sunday, July 25, 2010

Mad Men, Mad Industry - Sunday Op-Ed Piece

With the fourth season premier of "Mad Men" tonight on AMC, a cable drama set in the 60's advertising world, for those of our brethren across the pond, TSB started thinking about what would it take for America and the Medical Device Industry to capture the fundamentals of what once made this industry and country so great. At this stage of our evolution, we have to find comedy in how far we've come in such a short period of time by looking in the rear-view mirror. Many of our readers have the perception that TSB is antediluvian because of our disdain for louche behavior by those who call themselves leaders within the industry, yet, what would some of our readers do to go back to the old days when men drank a classic martini or a beer, rather than some tooty-fruity concoction that TSB sees some of you drinking at the bar? When you lit up a cigarette and no one was offended, and when you spanked your children when they didn't listen or did something wrong, rather than attempt to use some of that bullshit psychology that you've been taught to use by being your child's best friend rather than their parent.

Just like Sterling Cooper (the agency), many of us that have tenure in spine, are learning to start all over. Because just like Sterling Cooper, our industry is going to have to adapt to a new world and a new economy. Less is more. In many respects we will have to reign in our disreputable behavior if we are going to survive the last ten years. Just like the adversarial climate that exists in this country, today, we are a mirrored image of that hatred and intolerance. God only knows what awaits our future? But just like our children, who have their lives micro-managed by over doting parents calling them on their cell phone every twenty minutes, that have a life carved out of soccer at 10 a.m., t-ball at 12:00 p.m., a math tudor at 2 p.m., and fencing at 4:oo p.m. our industry is a microcosm of their lives. Maybe some of our Area VP's, Regional Manager's, CEO's and investors will take the time to watch this and learn that Mad Men is a reflection of our lives. Contracts are lost, the days of 20% growth end (hear me Stryker), people are not a seamless team, you don't have to account for every minute of your life because not everyone wants to buy your commodity product, and that your company is not the center of the universe. Yes, the characters on Mad Men are one-dimensional, but how many of you aren't? How much adult supervision do you really need?

Yes, fellow readers, we have made progress since the early days of spine when patient's were placed in full body casts, or even racked like Mel Gibson in Braveheart. But in our zeal for fame and fortune, we have driven the very essence of our humanity underground. You know when men were men and women were women. When multi-tasking was an idle concept rather than a neurotic disorder. When doctors wanted to be doctors except everything else than being a doctor. When salespeople sold and weren't considered brokers. So tune in tonight and remember who you are, you just might learn something about yourself.

Tuesday, July 20, 2010

Questions for Our Readers

How slow is business when one considers that even the Almighty Stryker reported flat sales for spine?

And,

Is there anything new and exciting in the Spine World?